Liu et al. (2020) reported that melatonin highly regulates serum amino acid levels in mice with inflammatory bowel disease; moreover, melatonin can alleviate insulin resistance and obesity by activating the AMPKα/PPARα signaling pathway. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.